FRITSCHE Jens;SINGH Harpreet;Immatics Biotechnologies GmbH;WEINSCHENK Toni;MAHR Andrea;OTT Martina;WAGNER Claudia;SCHOOR Oliver
发明人:
FRITSCHE Jens,SINGH Harpreet,WEINSCHENK Toni,MAHR Andrea,OTT Martina,WAGNER Claudia,SCHOOR Oliver
申请号：
IL25408117
公开号：
IL254081D0
申请日:
2017.08.21
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
